Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Using Light Therapy to Treat Toe Nail Fungus
This study is currently recruiting participants.
Verified by Nomir Medical Technologies, October 2008
Sponsored by: Nomir Medical Technologies
Information provided by: Nomir Medical Technologies
ClinicalTrials.gov Identifier: NCT00771732
  Purpose

To see if four sessions of light therapy successfully treats nail fungus.


Condition Intervention Phase
Onychomycosis
Device: light therapy
Phase II

MedlinePlus related topics: Molds
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Subject), Placebo Control, Single Group Assignment, Safety/Efficacy Study
Official Title: Noveon Laser Treatment of Onychomycosis: A Device Performance Clinical Study

Further study details as provided by Nomir Medical Technologies:

Primary Outcome Measures:
  • clinical improvement [ Time Frame: six months ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • mycological negative [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: May 2008
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Light therapy
Device: light therapy
6 minute light therapy
2: Sham Comparator
6 minute "session" given with machine "off"
Device: light therapy
combination of wavelengths

Detailed Description:

This study is a one year study which includes four treatment sessions of light therapy looking for clinical and mycological improvement.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • toe nail fungus, not infolving lunula
  • between ages 18-70 years old

Exclusion Criteria:

  • not on systemic anti-fungal medications
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00771732

Contacts
Contact: Mary E Oster 781-893-1000 m.oster@nomirmedical.com
Contact: Alan Robbins, M.D. 781-893-1000 alanhrobbins@comcast.com

Locations
United States, Massachusetts
Paula Angelini, DPM Recruiting
southborough, Massachusetts, United States, 02452
Contact: Paula Angelini, DPM     617-901-6421     Paula.Angelini@southboromedicalgroup.com    
Contact: Mary Oster     508-524-4632     m.oster@nomirmedical.com    
Sponsors and Collaborators
Nomir Medical Technologies
Investigators
Study Chair: Alan Robbins, M.D. Nomir Medical Technologies
  More Information

Responsible Party: Nomir Medical Technologies ( Nomir Medical Technologies )
Study ID Numbers: 09.002, 07-301
Study First Received: July 7, 2008
Last Updated: October 10, 2008
ClinicalTrials.gov Identifier: NCT00771732  
Health Authority: United States: Institutional Review Board

Keywords provided by Nomir Medical Technologies:
toe nail fungus

Study placed in the following topic categories:
Mycoses
Skin Diseases, Infectious
Onychomycosis
Skin Diseases
Tinea
Dermatomycoses

Additional relevant MeSH terms:
Nail Diseases
Infection

ClinicalTrials.gov processed this record on January 16, 2009